clinical trial · NCT04328298
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
The Lymphoma Academic Research Organisation·—·recruiting·n = 5,000
Hematopathology Eligible or CAR-t Cell Treatment
brief summary
This study is a registry including prospective and retrospective data on all patients who have been presented in a Multidisciplinary tumor board or RCP to be eligible for CAR-T cell treatment.
started
Dec 19, 2019
primary completion
Dec 19, 2038
completion
Dec 19, 2038
last updated
Mar 4, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol